These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18833070)

  • 1. Vasoactive peptides in the pathogenesis of psoriasis.
    Reich A; Szepietowski JC
    G Ital Dermatol Venereol; 2008 Oct; 143(5):289-98. PubMed ID: 18833070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neuropeptides in psoriasis.
    Saraceno R; Kleyn CE; Terenghi G; Griffiths CE
    Br J Dermatol; 2006 Nov; 155(5):876-82. PubMed ID: 17034513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of neuropeptides in dermatology].
    Sánchez-Carpintero I; España-Alonso A
    Rev Neurol; 1997 Sep; 25 Suppl 3():S222-31. PubMed ID: 9273166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes.
    Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S
    Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentration of selected neuropeptides in patients suffering from psoriasis.
    Reich A; Orda A; Wiśnicka B; Szepietowski JC
    Exp Dermatol; 2007 May; 16(5):421-8. PubMed ID: 17437485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and role of peptides with action on the cardiovascular system].
    Derchi G; Vecchio C
    G Ital Cardiol; 1993 Oct; 23(10):1029-42. PubMed ID: 7513662
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis.
    Chan J; Smoller BR; Raychauduri SP; Jiang WY; Farber EM
    Arch Dermatol Res; 1997 Oct; 289(11):611-6. PubMed ID: 9444383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immune function by intestinal neuropeptides.
    Sirinek LP; O'Dorisio MS
    Acta Oncol; 1991; 30(4):509-17. PubMed ID: 1713037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vasoactive neuropeptides on human saphenous vein.
    Luu TN; Chester AH; O'Neil GS; Tadjkarimi S; Yacoub MH
    Br Heart J; 1992 Jun; 67(6):474-7. PubMed ID: 1377922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The vasomotor effects of neuropeptides].
    Polenov SA; Dvoretskiĭ DP; Cherniavskaia GV
    Fiziol Zh Im I M Sechenova; 1995 Jun; 81(6):29-47. PubMed ID: 8845876
    [No Abstract]   [Full Text] [Related]  

  • 11. Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats.
    Adeghate E
    Neuropeptides; 1999 Jun; 33(3):227-35. PubMed ID: 10657496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides in dental pulp: the silent protagonists.
    Caviedes-Bucheli J; Muñoz HR; Azuero-Holguín MM; Ulate E
    J Endod; 2008 Jul; 34(7):773-88. PubMed ID: 18570980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries.
    Jansen I; Uddman R; Hocherman M; Ekman R; Jensen K; Olesen J; Stiernholm P; Edvinsson L
    Ann Neurol; 1986 Oct; 20(4):496-501. PubMed ID: 2431650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of neuropeptides in the physiopathogenesis of asthma].
    Onuma Takane E; López Pérez G; Huerta López JG; Pedroza Melendez A
    Rev Alerg; 1993; 40(3):71-5. PubMed ID: 7692583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of gastrointestinal motility by peptides: old peptides, new tricks--new peptides, old tricks.
    Fox JA
    Gastroenterol Clin North Am; 1989 Jun; 18(2):163-77. PubMed ID: 2474497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptides and asthma.
    Barnes PJ
    Am Rev Respir Dis; 1991 Mar; 143(3 Pt 2):S28-32. PubMed ID: 1706152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in nerves and neuropeptides in skin from 100 leprosy patients investigated by immunocytochemistry.
    Karanth SS; Springall DR; Lucas S; Levy D; Ashby P; Levene MM; Polak JM
    J Pathol; 1989 Jan; 157(1):15-26. PubMed ID: 2466111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuromediators in dermatology. Therapeutic prospectives].
    Claudy A
    Pathol Biol (Paris); 1996 Dec; 44(10):888-94. PubMed ID: 9157369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp.
    Caviedes-Bucheli J; Lombana N; Azuero-Holguín MM; Munoz HR
    Int Endod J; 2006 May; 39(5):394-400. PubMed ID: 16640639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.